Results 51 to 60 of about 106,218 (349)
Smoking and Idiopathic Pulmonary Fibrosis [PDF]
Pulmonary Medicine, 2012 Idiopathic pulmonary fibrosis (IPF) is a disease of unknown etiology with considerable morbidity and mortality. Cigarette smoking is one of the most recognized risk factors for development of IPF. Furthermore, recent work suggests that smoking may have a detrimental effect on survival of patients with IPF.
Chad K. Oh +2 more
openaire +4 more sources
Modelling Airway Geometry as Stock Market Data using Bayesian Changepoint Detection [PDF]
In Lecture Notes in Computer Science, vol 11861. (2019) Springer,
Cham, 2019 Numerous lung diseases, such as idiopathic pulmonary fibrosis (IPF), exhibit dilation of the airways. Accurate measurement of dilatation enables assessment of the progression of disease. Unfortunately the combination of image noise and airway bifurcations causes high variability in the profiles of cross-sectional areas, rendering the identification of ...
arxiv +1 more source
Pathogenesis of Idiopathic Pulmonary Fibrosis [PDF]
Annual Review of Pathology: Mechanisms of Disease, 2014 Idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease associated with aging that is characterized by the histopathological pattern of usual interstitial pneumonia. Although an understanding of the pathogenesis of IPF is incomplete, recent advances delineating specific clinical and pathologic features of IPF have led to better ...
Wolters, Paul J +2 more
openaire +6 more sources
Rethinking Idiopathic Pulmonary Fibrosis
Clinics in Chest Medicine, 2021 Idiopathic pulmonary fibrosis (IPF) is a devastating disease for patients and their loved ones. Since initial efforts to characterize this disease in the 1960s, understanding of IPF has evolved considerably. Such evolution has continually challenged prior diagnostic and treatment paradigms, ushering in an era of higher confidence diagnoses with less ...
Oldham, Justin M, Vancheri, Carlo
openaire +3 more sources
Trials, 2022 Background and rationale Idiopathic pulmonary fibrosis is a critical disease with a poor prognosis. Although different studies have been conducted for the treatment of idiopathic pulmonary fibrosis, limited treatments are available.
Shu-guang Yang +13 more
doaj +1 more source
Exacerbation of idiopathic pulmonary fibrosis [PDF]
Terapevticheskii arkhiv, 2020 Idiopathic pulmonary fibrosis (IPF) is usually characterized by a chronic and slowly progressive course. According to several studies, a small number of patients with IPF (about 515%) develops an acute deterioration of deasese exacerbation of IPF. Exacerbations of IPF can occur at any time of the disease and sometimes becomes the first manifestation ...
S. N. Avdeev +5 more
openaire +4 more sources
Imaging diagnosis-computed tomography of traction bronchiectasis secondary to pulmonary fibrosis in a Patterdale Terrier [PDF]
, 2016 An 8-year-old, Patterdale terrier was referred for evaluation of tachypnoea, exercise intolerance, and weight loss. Computed tomographic images showed pneumomediastinum, diffuse pulmonary ground glass opacity, and marked dilatation of peripheral bronchi,
Fitzgerald, E +2 more
core +2 more sources
Clinical significance of the determination of surfactant proteins A and D in assessing the activity of lung sarcoidosis [PDF]
Терапевтический архив, 2018 The results of a clinical study showing the importance of surfactant proteins A and D in assessing the activity and progression of idiopathic pulmonary fibrosis and chronic lung sarcoidosis are presented. Aim.
V D Beketov +9 more
doaj +1 more source
The treatment of idiopathic pulmonary fibrosis [PDF]
F1000Prime Reports, 2014 Idiopathic pulmonary fibrosis (IPF) is a progressive and invariably fatal disease with a median survival of less than three years from diagnosis. The last decade has seen an exponential increase in clinical trial activity in IPF and this in turn has led to important developments in the treatment of this terrible disease. Previous therapeutic approaches
Woodcock, HV, Maher, TM
openaire +5 more sources
Fibrosis-Net: A Tailored Deep Convolutional Neural Network Design for Prediction of Pulmonary Fibrosis Progression from Chest CT Images [PDF]
arXiv, 2021 Pulmonary fibrosis is a devastating chronic lung disease that causes irreparable lung tissue scarring and damage, resulting in progressive loss in lung capacity and has no known cure. A critical step in the treatment and management of pulmonary fibrosis is the assessment of lung function decline, with computed tomography (CT) imaging being a ...
arxiv